Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Virchows Arch ; 475(6): 801, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31667595

ABSTRACT

The name of the co-author of MD-05-001 (page S62) should be presented as 'S. Vári-Kakas' instead of 'I.î Vári-Kakas' in the authorship group. The name has been corrected in the authorship group shown above.

2.
Clin Exp Metastasis ; 34(1): 103-113, 2017 01.
Article in English | MEDLINE | ID: mdl-27885435

ABSTRACT

Phenotypical change in metastatic breast carcinoma has widely been accepted as an inherent biological feature rather than technical fault. We analyzed the immunohistochemical phenotype and histopathological features of 25 primary breast carcinomas and 90 corresponding distant metastases in 23 organs retrospectively. Histological slides were reviewed for prognostic and predictive factors. Overall, metastases were more similar to each other and often differed from the primary tumor. We created a 3-step grouping system based on the localization of metastases. Regions: tumors metastasizing to the abdominal region were likely to lose ER (p = 0.002); we detected loss of PR in metastases to the thorax (p = 0.039) and abdomen (p < 0.001). Organ systems: loss of ER and PR was observed in metastases to the gastrointestinal system (p = 0.026 and p = 0.001, respectively), in the respiratory system only the loss of PR was significant (p = 0.05). Individual organs: the primaries were likely to lose the hormone receptors in liver metastases (ER p = 0.026; PR p = 0.004). In lung metastases only loss of PR was apparent (p = 0.049). We did not observe significant change in HER2 status, regarding Ki67 change occurred only in bone metastases compared to the primary (p = 0.048). 7/25 patients' distant metastases had heterogeneous immunoprofiles. The later the metastasis was discovered the more likely it had a differing IHC profile compared to the primary tumor, patients who had longer OS had a higher chance to develop a discordant metastasis. Immunoprofile of metastases may differ from primary breast cancer and from each other, probably resulting in different response to therapy.


Subject(s)
Bone Neoplasms/pathology , Breast Neoplasms/pathology , Carcinoma/pathology , Lung Neoplasms/pathology , Adult , Aged , Autopsy , Bone Neoplasms/epidemiology , Bone Neoplasms/immunology , Bone Neoplasms/secondary , Breast Neoplasms/epidemiology , Breast Neoplasms/immunology , Carcinoma/epidemiology , Carcinoma/immunology , Female , Humans , Immunophenotyping , Liver Neoplasms/epidemiology , Liver Neoplasms/immunology , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Lung Neoplasms/epidemiology , Lung Neoplasms/immunology , Lung Neoplasms/secondary , Middle Aged , Neoplasm Metastasis , Prognosis
4.
Breast Cancer Res Treat ; 157(1): 65-75, 2016 05.
Article in English | MEDLINE | ID: mdl-27116185

ABSTRACT

The Nottingham prognostic index plus (NPI+) is based on the assessment of biological class combined with established clinicopathologic prognostic variables providing improved patient outcome stratification for breast cancer superior to the traditional NPI. This study aimed to determine prognostic capability of the NPI+ in predicting risk of development of distant disease. A well-characterised series of 1073 primary early-stage BC cases treated in Nottingham and 251 cases from Budapest were immunohistochemically assessed for cytokeratin (Ck)5/6, Ck18, EGFR, oestrogen receptor (ER), progesterone receptor, HER2, HER3, HER4, Mucin 1 and p53 expression. NPI+ biological class and prognostic scores were assigned using individual algorithms for each biological class incorporating clinicopathologic parameters and investigated in terms of prediction of distant metastases-free survival (MFS). The NPI+ identified distinct prognostic groups (PG) within each molecular class which were predictive of MFS providing improved patient outcome stratification superior to the traditional NPI. NPI+ PGs, between series, were comparable in predicting patient outcome between series in luminal A, basal p53 altered and HER2+/ER+ (p > 0.01) tumours. The low-risk groups were similarly validated in luminal B, luminal N, basal p53 normal tumours (p > 0.01). Due to small patient numbers the remaining PGs could not be validated. NPI+ was additionally able to predict a higher risk of metastases at certain distant sites. This study may indicate the NPI+ as a useful tool in predicting the risk of metastases. The NPI+ provides accurate risk stratification allowing improved individualised clinical decision making for breast cancer.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Adult , Aged , Aged, 80 and over , ErbB Receptors/metabolism , Female , Humans , Keratins/metabolism , Middle Aged , Mucin-1/metabolism , Neoplasm Metastasis , Prognosis , Receptor, ErbB-2/metabolism , Receptor, ErbB-3/metabolism , Receptor, ErbB-4/metabolism , Receptors, Estrogen/metabolism , Survival Analysis , Tumor Suppressor Protein p53/metabolism
5.
Acta Physiol Hung ; 99(3): 279-88, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22982716

ABSTRACT

UNLABELLED: To clarify the effects of dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS) on arteriolar biomechanics in a rat model and the possible modulatory role of vitamin D3. METHODS AND RESULTS: The PCOS model was induced in female Wistar rats by ten-weeks DHT treatment. Arteriolar biomechanics was tested in arterioles by pressure arteriography in control as well as DHT- and DHT with vitamin D3-treated animals in contracted and passive conditions. Increased wall stress and distensibility as well as increased vascular lumen were detected after DHT treatment. Concomitant vitamin D3 treatment lowered the mechanical load of the arterioles and restored the vascular diameter. CONCLUSION: The hyperandrogenic state resulted in more rigid, less flexible arteriolar walls with increased vascular lumen compared with controls. DHT treatment caused eutrophic remodelling of gracilis arteriole. These prehypertensive alterations caused by chronic DHT treatment were mostly reversed by concomitant vitamin D3 administration.


Subject(s)
Arterioles/drug effects , Arterioles/physiology , Cholecalciferol/pharmacology , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/physiopathology , Prehypertension/prevention & control , Adaptation, Physiological/physiology , Animals , Biomechanical Phenomena/drug effects , Biomechanical Phenomena/physiology , Disease Models, Animal , Elasticity/physiology , Female , Muscle, Skeletal/blood supply , Prehypertension/physiopathology , Rats , Rats, Wistar , Stress, Mechanical , Vitamins/pharmacology
6.
Clin Exp Metastasis ; 28(1): 55-63, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20963473

ABSTRACT

Adherent and tight junction molecules have been described to contribute to carcinogenesis and tumor progression. Additionally, the group of claudin-low tumors have recently been identified as a molecular subgroup of breast carcinoma. In our study, we examined the expression pattern of claudins, beta-catenin and E-cadherin in invasive ductal (IDCs) and lobular (ILCs) carcinomas and their corresponding lymph node metastases (LNMs). Tissue microarrays of 97 breast samples (60 invasive ductal carcinomas, 37 invasive lobular carcinomas) and their corresponding LNMs have been analyzed immunohistochemically for claudin-1, -2, -3, -4, -5, -7, beta-catenin and E-cadherin expression. The stained slides were digitalized with a slide scanner and the reactions were evaluated semiquantitatively. When compared to LNMs, in the IDC group beta-catenin and claudin-2, -3, -4 and -7 protein expression showed different pattern while claudin-1, -2, -3, -4 and -7 were differently expressed in the ILC group. Lymph node metastases developed a notable increase of claudin-5 expression in both groups. Decrease or loss of claudin-1 and expression of claudin-4 in lymph node metastases correlated with reduced disease-free survival in our patients. According to our observations, the expression of epithelial junctional molecules, especially claudins, is different in primary breast carcinomas compared to their lymph node metastases as demonstrated by immunohistochemistry. Loss of claudin junctional molecules might contribute to tumor progression, and certain claudin expression pattern might be of prognostic relevance.


Subject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/metabolism , Claudins/biosynthesis , Lymphatic Metastasis/diagnosis , Breast Neoplasms/pathology , Claudins/metabolism , Disease-Free Survival , Female , Humans , Immunohistochemistry , Lymphatic Metastasis/genetics , Middle Aged , Prognosis , Tissue Array Analysis
7.
Pathol Res Pract ; 197(2): 109-12, 2001.
Article in English | MEDLINE | ID: mdl-11261814

ABSTRACT

The purpose of this study was to determine the effects of ovariectomy and long-term combined sexual hormone replacement on the gap junctional protein, connexin 43 (Cx43) of aortic medial smooth muscle cells in rats. Twenty non-pregnant mature Wistar female rats were divided into five groups (four animals in each group). Group A underwent ovariectomy, Group B underwent ovariectomy and received estradiol propionate, Group C underwent ovariectomy and received medroxyprogesterone acetate and Group D underwent ovariectomy and received both hormones. Group E was sham-operated and used as control. After 15 weeks of treatment, thoracic aortas were removed and immunohistochemistry was carried out using a specific fluorescent antibody against Cx43. Tissue sections were examined by confocal laser scanning microscopy and analysed by the Scion Image program. All five different groups had the same distribution and extent of Cx43 in the aorta. Neither the ovariectomy nor the hormone replacement had any effect on the Cx43 expression of aortic smooth muscle cells in rats as compared to control animals. These results indicate that sexual steroids do not influence the gap junctional protein Cx43 of the medial layer of aorta in rats. They may suggest that the beneficial effects of estrogen are not mediated via gap junctions in the human aorta either.


Subject(s)
Aorta, Thoracic/metabolism , Connexin 43/metabolism , Estradiol/pharmacology , Estrogen Replacement Therapy , Medroxyprogesterone Acetate/pharmacology , Muscle, Smooth, Vascular/metabolism , Ovariectomy , Animals , Aorta, Thoracic/drug effects , Drug Combinations , Female , Fluorescent Antibody Technique, Indirect , Image Processing, Computer-Assisted , Muscle, Smooth, Vascular/drug effects , Rats , Rats, Wistar
8.
J Hypertens ; 18(11): 1587-95, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11081771

ABSTRACT

OBJECTIVES: To test the effects of chronic angiotensin II administration on blood pressure and small artery biomechanics in the female sex hormone-depleted state (proposed to increase cardiovascular vulnerability) and with hormone replacement. DESIGN: Biomechanical properties of saphenous artery segments from ovariectomized (n = 10), ovariectomized + chronically angiotensin II infused-(n = 10), and ovariectomized + chronically angiotensin II-infused + sex hormone-replaced (n = 10) rats were studied. METHODS: Surgical ovariectomy was performed. Osmotic minipumps were used for chronic angiotensin II infusion (100 ng/min per kg). For hormone replacement therapy, oestradiol-propionate, 450 microg/kg for 7 days + medroxyprogesterone-acetate, 15 mg/kg for 14 days were given, intramuscularly. After 4 weeks, cylindrical segments of the saphenous artery were prepared and subjected to in-vitro microarteriographic measurements. Pressure-diameter curves (0-200 mmHg) were recorded in Krebs-Ringer solution, with smooth muscle contracted (norepinephrine, 16 micromol/l) and with relaxed (papaverine, 28 micromol/l). RESULTS: Chronic angiotensin II infusion significantly reduced the inner radius (at 100 mmHg: 298 +/- 17 microm versus 347 +/- 7 microm, P< 0.001), while wall-thickness did not change. Hormone replacement restored the morphological radius (333 +/- 7 microm). Angiotensin II infusion slightly increased the full contraction range of the segments (defined as the percentage difference between fully contracted and fully relaxed diameters), which was further significantly increased by hormone replacement (39 +/- 4%, 46 +/- 8%, 62 +/- 7% at 100 mmHg, in the three groups, respectively; P < 0.05). Despite unaltered stiffness in relaxed state, elastic moduli computed for the contracted segments decreased after hormone replacement. CONCLUSIONS: These observations give further experimental support to the hypothesis that sex hormone replacement might be useful in preventing the development and/or stabilization of postmenopausal hypertension, as well as in treating existing disease.


Subject(s)
Estradiol/pharmacology , Hormone Replacement Therapy , Hypertension/drug therapy , Ovariectomy , Angiotensin II/pharmacology , Animals , Arterioles/drug effects , Arterioles/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , Elasticity , Female , Hypertension/chemically induced , Medroxyprogesterone Acetate/pharmacology , Menopause , Progesterone Congeners/pharmacology , Rats , Rats, Sprague-Dawley , Vascular Resistance/drug effects , Vascular Resistance/physiology , Vasoconstriction/drug effects , Vasoconstriction/physiology , Vasoconstrictor Agents/pharmacology , Weight Gain
9.
Pathol Oncol Res ; 6(3): 202-9, 2000.
Article in English | MEDLINE | ID: mdl-11033461

ABSTRACT

Tenascin is generally classified as an anti-adhesive protein. Many cells do not adhere to tenascin or if they adhere they do not spread. In this study we analysed the stromal expression of tenascin-C in primary, second primary and recurrent breast carcinomas and the ability of tenascin-C to stimulate the focal adhesion plaques in MDA-MB-435 breast carcinoma cell line. To assess the tenascin-C expression formalin-fixed, paraffin-embedded specimens of 20 specially selected breast carcinomas and their recurrences (14) or a second primary breast cancer of the same patient (6) were examined with immunohistochemical methods. We also studied the effect of tenascin-C on focal adhesion plaques added to MDA-MB-435 breast carcinoma cell line. During a median 2,9-year patient follow up 14 local recurrences and 6-second primary breast carcinomas developed in the 20 patients. In 3 cases a second recurrence occurred. The presence of tenascin in tumor cells, in the proliferating and some normal ducts, near to the tumor cell nests, in the stroma and in ductal carcinoma in situ component of the invasive carcinoma may suggest the role of tenascin played in tumor cell migration. Soluble tenascin added to the cell culture had minimal or no effect on focal adhesion plaques. Tenascin only seems not to be of prognostic value in predicting the local recurrence of breast cancer.


Subject(s)
Breast Neoplasms/metabolism , Carcinoma/metabolism , Neoplasm Recurrence, Local/metabolism , Tenascin/metabolism , Tenascin/pharmacology , Tumor Cells, Cultured/drug effects , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma/pathology , Carcinoma/surgery , Female , Fluorescent Antibody Technique, Indirect , Focal Adhesions/metabolism , Focal Adhesions/pathology , Humans , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery
10.
Anticancer Res ; 19(1A): 175-9, 1999.
Article in English | MEDLINE | ID: mdl-10226540

ABSTRACT

BACKGROUND: The association of TN expression, tumour grading and expression of commonly used histopathologic prognostic factors (p53 and estrogen receptor) was examined in 62 cases of invasive ductal carcinoma of the breast. MATERIAL AND METHODS: Following histological grading immunohistochemical reactions were undertaken on routine histopathologic samples and the results semiquantitatively evaluated. RESULTS: Strong TN expression was found in close proximity of the neoplastic epithelial cells in each case, but not in other areas of the stroma. In 10 (16%) cases TN expression was detected to the neoplastic epithelial cells as well. There was no statistically significant difference in the extent of stromal TN immunoreaction between tumours of different grades. A significant difference was found in p53 and estrogen receptor immunoreactions by tumour grade (p = 0.05). TN immunoreaction in the stroma did not correlate with the nuclear expression of p53, Ki-67 and estrogen receptor in the tumour cells. CONCLUSIONS: TN immunoreactivity does not seem to correlate with currently used prognostic factors. The increased expression of stromal TN in invasive breast ductal carcinomas is an other indicator of possible role played by the extracelular matrix components in cancer development.


Subject(s)
Breast Neoplasms/chemistry , Carcinoma, Ductal, Breast/chemistry , Tenascin/analysis , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Female , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Receptors, Estrogen/analysis , Tenascin/immunology , Tumor Suppressor Protein p53/analysis
11.
Pathol Res Pract ; 195(12): 821-8, 1999.
Article in English | MEDLINE | ID: mdl-10631717

ABSTRACT

The expression and the distribution of tenascin as well as the extent of blood vessel formation (angiogenesis) were investigated in 70 invasive human breast carcinomas. Formalin-fixed, paraffin-embedded specimens were stained with monoclonal antibody against tenascin-C (DAKO and Biogenex). Anti-CD31 antibody (Biogenex), an acknowledged marker of stromal angiogenesis, was used to detect endothelial cells. Tenascin immunostaining was positive in the tumours around the persisting normal ducts, around tumour-cell nests, in the neostroma, in some tumour cells, and it was found in or around vascular channels. Tumour vascularity was assessed by quantitative vascular grading (Chalkley point count) and was related to the localization and intensity of tenascin immunoreactivity. 19 tumours (27.1%) were scored as low, 35 (50%) as medium, and 16 (22.9%) as having a high vascular grade. The positive correlation between the vascular grade and the tenascin immunopositivity in tumour stroma was observed. Our results suggest that tenascin expression may be associated with endothelial cell activation and may play an important role in tumour angiogenesis.


Subject(s)
Breast Neoplasms/blood supply , Carcinoma, Ductal, Breast/blood supply , Neovascularization, Pathologic/metabolism , Tenascin/metabolism , Adult , Aged , Aged, 80 and over , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Ductal, Breast/pathology , Female , Humans , Immunoenzyme Techniques , Ki-67 Antigen/metabolism , Middle Aged , Neoplasm Staging , Neovascularization, Pathologic/pathology , Prognosis , Receptors, Estrogen/metabolism , Tumor Suppressor Protein p53/metabolism
12.
Nutr Metab Cardiovasc Dis ; 9(5): 220-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10656168

ABSTRACT

BACKGROUND AND AIM: The present work is a chapter in an investigation directed by the World Health Organization on the Pathobiological Determinants of Atherosclerosis In Youth (WHO-PBDAY). Our aim was to study the development of atherosclerotic lesions in a young population. METHODS AND RESULTS: Samples of left anterior descending coronary artery (LDC) and thoracic (TA) and abdominal aorta (AA) from five Collaborating Centres (Budapest/Hungary, Havana/Cuba, Heidelberg/Germany, Mexico City/Mexico, Peradeniya/Sri Lanka) of 214 subjects who died aged 15 and 34 were analysed at the Budapest Reference Centre. Slides stained with haematoxylin-eosin and with stains for extracellular matrix were quantitatively and qualitatively evaluated. Mean intima/media (I/M) ratio and the prevalence of type III-IV lesions (preatheroma; atheroma; calcified and fibrous atheroma) were determined and compared in different risk factor (high blood pressure, smoking) groups. High I/M ratio was found in the LDC and type III-IV lesions were frequently found both in the LDC and in the AA. I/M ratio and the occurrence of type III-IV lesions increased in all arteries by age. Atherosclerotic lesions in men were more severe, particularly in the LDC. Geographic origin had a limited effect on the histologic lesion parameters. Appearance of type III-IV lesions was associated with substantially different extracellular matrix changes. Myoelastic layer formation was found in each artery in both early and type III-IV lesions. Hypertension was associated with higher prevalence of type III-IV lesions in all arteries, in particular, in the TA; smoking showed a significant effect on the AA only. CONCLUSIONS: Atherosclerotic lesions were found in many of these young subjects. The effect of hypertension and smoking on their development suggests that control of risk factors, beginning in early adolescence, could help to prevent cardiovascular diseases.


Subject(s)
Aorta, Abdominal/pathology , Aorta, Thoracic/pathology , Arteriosclerosis/epidemiology , Arteriosclerosis/pathology , Coronary Vessels/pathology , Adolescent , Adult , Age Factors , Arteriosclerosis/etiology , Arteriosclerosis/prevention & control , Female , Global Health , Histocytochemistry , Humans , Hypertension/complications , Male , Prevalence , Risk Factors , Severity of Illness Index , Sex Factors , Smoking/adverse effects , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL
...